Cargando…
Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked recessive disease caused by mutations in the dystrophin gene. Transplantation of myogenic stem cells holds great promise for treating muscular dystrophies. However, poor engraftment of myogenic stem cells limits the therapeutic effec...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501581/ https://www.ncbi.nlm.nih.gov/pubmed/34627382 http://dx.doi.org/10.1186/s13287-021-02594-1 |
_version_ | 1784580713493823488 |
---|---|
author | Elhussieny, Ahmed Nogami, Ken’ichiro Sakai-Takemura, Fusako Maruyama, Yusuke Takemura, Natsumi Soliman, Wael Talaat Takeda, Shin’ichi Miyagoe-Suzuki, Yuko |
author_facet | Elhussieny, Ahmed Nogami, Ken’ichiro Sakai-Takemura, Fusako Maruyama, Yusuke Takemura, Natsumi Soliman, Wael Talaat Takeda, Shin’ichi Miyagoe-Suzuki, Yuko |
author_sort | Elhussieny, Ahmed |
collection | PubMed |
description | BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked recessive disease caused by mutations in the dystrophin gene. Transplantation of myogenic stem cells holds great promise for treating muscular dystrophies. However, poor engraftment of myogenic stem cells limits the therapeutic effects of cell therapy. Mesenchymal stem cells (MSCs) have been reported to secrete soluble factors necessary for skeletal muscle growth and regeneration. METHODS: We induced MSC-like cells (iMSCs) from induced pluripotent stem cells (iPSCs) and examined the effects of iMSCs on the proliferation and differentiation of human myogenic cells and on the engraftment of human myogenic cells in the tibialis anterior (TA) muscle of NSG-mdx(4Cv) mice, an immunodeficient dystrophin-deficient DMD model. We also examined the cytokines secreted by iMSCs and tested their effects on the engraftment of human myogenic cells. RESULTS: iMSCs promoted the proliferation and differentiation of human myogenic cells to the same extent as bone marrow-derived (BM)-MSCs in coculture experiments. In cell transplantation experiments, iMSCs significantly improved the engraftment of human myogenic cells injected into the TA muscle of NSG-mdx(4Cv) mice. Cytokine array analysis revealed that iMSCs produced insulin-like growth factor-binding protein 2 (IGFBP2), urokinase-type plasminogen activator receptor (uPAR), and brain-derived neurotrophic factor (BDNF) at higher levels than did BM-MSCs. We further found that uPAR stimulates the migration of human myogenic cells in vitro and promotes their engraftment into the TA muscles of immunodeficient NOD/Scid mice. CONCLUSIONS: Our results indicate that iMSCs are a new tool to improve the engraftment of myogenic progenitors in dystrophic muscle. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02594-1. |
format | Online Article Text |
id | pubmed-8501581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85015812021-10-20 Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) Elhussieny, Ahmed Nogami, Ken’ichiro Sakai-Takemura, Fusako Maruyama, Yusuke Takemura, Natsumi Soliman, Wael Talaat Takeda, Shin’ichi Miyagoe-Suzuki, Yuko Stem Cell Res Ther Research BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked recessive disease caused by mutations in the dystrophin gene. Transplantation of myogenic stem cells holds great promise for treating muscular dystrophies. However, poor engraftment of myogenic stem cells limits the therapeutic effects of cell therapy. Mesenchymal stem cells (MSCs) have been reported to secrete soluble factors necessary for skeletal muscle growth and regeneration. METHODS: We induced MSC-like cells (iMSCs) from induced pluripotent stem cells (iPSCs) and examined the effects of iMSCs on the proliferation and differentiation of human myogenic cells and on the engraftment of human myogenic cells in the tibialis anterior (TA) muscle of NSG-mdx(4Cv) mice, an immunodeficient dystrophin-deficient DMD model. We also examined the cytokines secreted by iMSCs and tested their effects on the engraftment of human myogenic cells. RESULTS: iMSCs promoted the proliferation and differentiation of human myogenic cells to the same extent as bone marrow-derived (BM)-MSCs in coculture experiments. In cell transplantation experiments, iMSCs significantly improved the engraftment of human myogenic cells injected into the TA muscle of NSG-mdx(4Cv) mice. Cytokine array analysis revealed that iMSCs produced insulin-like growth factor-binding protein 2 (IGFBP2), urokinase-type plasminogen activator receptor (uPAR), and brain-derived neurotrophic factor (BDNF) at higher levels than did BM-MSCs. We further found that uPAR stimulates the migration of human myogenic cells in vitro and promotes their engraftment into the TA muscles of immunodeficient NOD/Scid mice. CONCLUSIONS: Our results indicate that iMSCs are a new tool to improve the engraftment of myogenic progenitors in dystrophic muscle. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02594-1. BioMed Central 2021-10-09 /pmc/articles/PMC8501581/ /pubmed/34627382 http://dx.doi.org/10.1186/s13287-021-02594-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Elhussieny, Ahmed Nogami, Ken’ichiro Sakai-Takemura, Fusako Maruyama, Yusuke Takemura, Natsumi Soliman, Wael Talaat Takeda, Shin’ichi Miyagoe-Suzuki, Yuko Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) |
title | Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) |
title_full | Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) |
title_fullStr | Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) |
title_full_unstemmed | Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) |
title_short | Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) |
title_sort | mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (upar) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501581/ https://www.ncbi.nlm.nih.gov/pubmed/34627382 http://dx.doi.org/10.1186/s13287-021-02594-1 |
work_keys_str_mv | AT elhussienyahmed mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar AT nogamikenichiro mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar AT sakaitakemurafusako mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar AT maruyamayusuke mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar AT takemuranatsumi mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar AT solimanwaeltalaat mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar AT takedashinichi mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar AT miyagoesuzukiyuko mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar |